GlassScriptPhysician profile
John P Kelly
NPI 1558704775
$19,219.66
in general payments reported to CMS, 2019-2025
49 companies · $3,921 in 2025
The $3,921 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,451 · 2022: $3,751 · 2023: $3,201 · 2024: $3,897 · 2025: $3,921.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,018.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,830.43 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $2,705.80 | 2021-2025 | |
| Amgen INC. | $2,605.89 | 2021-2025 | Repatha, Otezla, Otezla |
| Glaxosmithkline, LLC. | $1,740.08 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $1,165.85 | 2021-2025 | |
| Novo Nordisk INC | $1,136.04 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Gilead Sciences, INC. | $1,055.83 | 2021-2025 | |
| Lilly USA, LLC | $1,028.87 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $458.22 | 2021-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $455.62 | 2021-2023 | Belsomra, Steglatro |
| Currax Pharmaceuticals LLC | $405.91 | 2022-2024 | Contrave, Onzetra Xsail, Nexletol |
| Novartis Pharmaceuticals Corporation | $404.62 | 2021-2025 | |
| Exact Sciences Corporation | $266.53 | 2023-2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $198.99 | 2021-2025 | Zoryve |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.04 | 2021-2025 | Xifaxan |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $176.80 | 2024-2025 | Nexletol |
| Viiv Healthcare Company | $170.11 | 2022-2025 | Apretude |
| Dexcom, INC. | $169.03 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.67 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $142.90 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $137.76 | 2021-2022 | |
| Cequr Corporation | $134.12 | 2024 | Cequr Simplicity |
| Astellas Pharma US INC | $133.92 | 2024-2025 | Veozah |
| Intuity Medical INC | $131.96 | 2022 | |
| Phathom Pharmaceuticals, INC. | $103.91 | 2024-2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $102.04 | 2023 | |
| Sumitomo Pharma America, INC. | $96.17 | 2025 | Gemtesa |
| Ani Pharmaceuticals, INC. | $89.30 | 2025 | Purified Cortrophin Gel |
| Biohaven Pharmaceutical Holding Company LTD. | $86.90 | 2022 | |
| Inspire Medical Systems, INC. | $77.82 | 2025 | Inspire |
| Otsuka America Pharmaceutical, INC. | $63.00 | 2024 | Rexulti |
| Edwards Lifesciences Corporation | $62.49 | 2024-2025 | Sapien 3 Ultra Resilia |
| Teva Pharmaceuticals USA, INC. | $61.38 | 2021 | |
| Intra-Sana Laboratories | $52.45 | 2024-2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Sanofi-Aventis U.S. LLC | $50.02 | 2021-2022 | |
| Renalytix Ai, INC. | $44.62 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Actelion Pharmaceuticals US, INC. | $43.33 | 2024 | Uptravi, Opsumit |
| Axsome Therapeutics, INC. | $37.23 | 2025 | Symbravo |
| Vanda Pharmaceuticals INC. | $30.28 | 2024 | Fanapt |
| Vertex Pharmaceuticals Incorporated | $29.17 | 2025 | |
| Medicomp INC | $27.69 | 2025 | Telepatch Cardiac Monitor |
| Baxter Healthcare | $24.16 | 2023 | Hillrom - Microtymp 4 Portable Tympanometric Instrument |
| Lundbeck LLC | $22.19 | 2025 | Vyepti |
| Amarin Pharma, INC. | $21.48 | 2022 | |
| Philips North America LLC | $20.95 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $19.25 | 2021 | |
| Urovant Sciences INC | $19.04 | 2022 | |
| Vistapharm, INC. | $15.00 | 2021 | |
| Eisai INC. | $11.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.